Multiple system atrophy - cerebellar subtype (msa-C)
Clinical trials for Multiple system atrophy - cerebellar subtype (msa-C) explained in plain language.
Never miss a new study
Get alerted when new Multiple system atrophy - cerebellar subtype (msa-C) trials appear
Sign up with your email to follow new studies for Multiple system atrophy - cerebellar subtype (msa-C), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial hopes to slow rare brain disorder
Disease control Recruiting nowThis early-stage study tests a new drug, ALT001, in 20 people with a rare brain disease called multiple system atrophy-cerebellar type (MSA-C). The main goal is to check if the drug is safe and tolerable. Researchers will also look for early signs that it might help control the d…
Matched conditions: MULTIPLE SYSTEM ATROPHY - CEREBELLAR SUBTYPE (MSA-C)
Early phase 1 • Sponsor: yilong Wang • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Brain zaps may ease rare movement disorder
Symptom relief Recruiting nowThis study tests a safe, non-invasive brain stimulation technique called tDCS to see if it can improve movement and balance in people with a rare neurological condition called Multiple System Atrophy - Cerebellar type (MSA-C). About 30 participants will receive either real or sha…
Matched conditions: MULTIPLE SYSTEM ATROPHY - CEREBELLAR SUBTYPE (MSA-C)
Sponsor: University of Salerno • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
DNA hunt for rare brain disease genes begins
Knowledge-focused Recruiting nowThis study collects DNA from up to 1,000 adults with progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple system atrophy (MSA), or related conditions, plus their family members. Researchers will sequence participants' whole genomes to find genetic variants …
Matched conditions: MULTIPLE SYSTEM ATROPHY - CEREBELLAR SUBTYPE (MSA-C)
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC